Larvol Delta - CA2099KU-A-Study-of-Nivolumab-In-Combination-With-Cabozantinib-in-Patients-With-NonClear-Cell-Renal-Cell-Carcinoma

Imfinzi (durvalumab) - AstraZeneca

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

atigotatug/nivolumab (BMS-986489) - BMS

http://clinicaltrials.gov/ct2/show/NCT06773910

Sep 22, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next